Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure

被引:31
作者
Guazzi, M
Tumminello, G
Di Marco, F
Guazzi, MD
机构
[1] Univ Milan, Inst Cardiol, Cardiopulm Lab, Div Cardiol, I-20138 Milan, Italy
[2] Univ Milan, Resp Unit, St Paolo Hosp, I-20138 Milan, Italy
关键词
D O I
10.1016/j.clpt.2004.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Chronic heart failure (CHF) may be associated with a disordered nitric oxide (NO)-mediated regulation of the pulmonary vessel tone and permeability and of the gas transfer across the alveolar-capillary membrane. Whether enhancement of NO availability is beneficial with regard to these functions has not been explored. Phosphodiesterase 5 inhibitors, such as sildenafil, may provide a tool with which to test this possibility. Methods: In 10 patients with CHF and 10 normal subjects, before and at 60 minutes after sildenafil (50 mg) or placebo, we measured left ventricular ejection fraction, pulmonary hemodynamics, lung diffusion capacity for carbon monoxide and its alveolar-capillary membrane and blood capillary volume subcomponents, and flow-mediated brachial artery dilation (FMD) during reactive hyperemia to distal circulatory arrest (an indirect index of NO-mediated endothelial function). Results: In patients with CHF, sildenafil caused no variations in ejection fraction, cardiac index, wedge pulmonary pressure, and blood capillary volume; it decreased pulmonary artery systolic (-21.6%) and diastolic (-31.8%) pressure and arteriolar resistance (-36.9%); and it increased lung diffusion capacity for carbon monoxide (+11.2%), diffusing capacity of the alvcolar-capillary membrane (+10.6%), and FMD (from +8.3% to +13.4%). All changes were significant at P <.01. None of these effects was observed in healthy subjects. Placebo was ineffective in both patients and control subjects. Conclusion: This study provides the novel information that, in patients with CHF, phosphodiesterase 5 inhibition with sildenafil ameliorates the pulmonary hemodynamics and reduces the impedance of the alveolar-capillary interface, even if left ventricular filling pressure and function remain steady. The associated improvement in FMD at the periphery substantiates the possibility that an enhancement in NO release may underlie these effects.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 25 条
[1]   NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GOOCH, VM ;
SPIEGELHALTER, DJ ;
MILLER, OI ;
SULLIVAN, ID ;
LLOYD, JK ;
DEANFIELD, JE .
LANCET, 1992, 340 (8828) :1111-1115
[2]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[3]   The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men [J].
Dishy, V ;
Sofowora, G ;
Harris, PA ;
Kandcer, M ;
Zhan, F ;
Wood, AJJ ;
Stein, CM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (03) :270-279
[4]   REDUCED EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].
GIAID, A ;
SALEH, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) :214-221
[5]   Alveolar-capillary membrane dysfunction in heart failure - Evidence of a pathophysiologic role [J].
Guazzi, M .
CHEST, 2003, 124 (03) :1090-1102
[6]   Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect [J].
Guazzi, M ;
Brambilla, R ;
De Vita, S ;
Guazzi, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (07) :978-982
[7]   Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril, and not by losartan, in chronic heart failure [J].
Guazzi, M ;
Agostoni, P ;
Guazzi, MD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :398-406
[8]  
Guazzi M, 1997, CIRCULATION, V95, P1930
[9]   Nitric oxide attenuates H2O2-induced endothelial barrier dysfunction:: mechanisms of protection [J].
Gupta, MP ;
Ober, MD ;
Patterson, C ;
Al-Hassani, M ;
Natarajan, V ;
Hart, CM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (01) :L116-L126
[10]   cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i [J].
He, P ;
Zeng, M ;
Curry, FE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (06) :H1865-H1874